A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Immunology, Immunotherapy"
DOI: 10.1007/s00262-018-2282-1
Abstract: Targeting immune checkpoint pathways, such as programmed death ligand-1 (PD-L1, also known as CD274 or B7-H1) or its receptor programmed cell death-1 (PD-1) has shown improved survival for patients with numerous types of cancers, not… read more here.
Keywords: variant; secreted splice; splice variant; cell ... See more keywords